Literature DB >> 15896318

Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin.

Wang Xi1, Hiroko Satoh, Hiroyuki Kase, Kunihiro Suzuki, Yoshiyuki Hattori.   

Abstract

The present study examined potential interactions between endothelial NO synthase (eNOS), heat shock protein (HSP)90, and Akt in vascular endothelial cells stimulated with globular adiponectin to produce nitric oxide (NO). Globular adiponectin-induced eNOS phosphorylation was accompanied by eNOS-HSP90-Akt complex formation, resulting in a dose-dependent increase in NO release. Globular adiponectin stimulated binding of HSP90 to eNOS, and inhibition of HSP90 significantly suppressed globular adiponectin-stimulated NO release. Globular adiponectin also caused Akt phosphorylation, and inhibition of PI3 kinase significantly suppressed globular adiponectin-stimulated NO release. This study also examined whether globular adiponectin really induces endothelial-dependent vasodilation using rings from rat thoracic aorta. It was observed that globular adiponectin caused dose-dependent vasorelaxation in the aorta. These results indicate that stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced eNOS phosphorylation and NO production, and to endothelium-dependent vasorelaxation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896318     DOI: 10.1016/j.bbrc.2005.04.111

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  45 in total

1.  Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice.

Authors:  Ricky Cheung; Fran Shen; Joseph H Phillips; Mandy J McGeachy; Daniel J Cua; Paul G Heyworth; Robert H Pierce
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 2.  Systemic adiponectin malfunction as a risk factor for cardiovascular disease.

Authors:  Wayne Bond Lau; Ling Tao; Yajing Wang; Rong Li; Xin L Ma
Journal:  Antioxid Redox Signal       Date:  2011-04-20       Impact factor: 8.401

Review 3.  Protective vascular and myocardial effects of adiponectin.

Authors:  Barry J Goldstein; Rosario G Scalia; Xin L Ma
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-11-25

4.  Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control.

Authors:  Asmaa I Matouk; Ashraf Taye; Mohamed A El-Moselhy; Gehan H Heeba; Abdel A Abdel-Rahman
Journal:  Eur J Pharmacol       Date:  2017-12-20       Impact factor: 4.432

Review 5.  Nitric oxide signalling in cardiovascular health and disease.

Authors:  Charlotte Farah; Lauriane Y M Michel; Jean-Luc Balligand
Journal:  Nat Rev Cardiol       Date:  2018-02-01       Impact factor: 32.419

6.  Regulation of iNOS-Derived ROS Generation by HSP90 and Cav-1 in Porcine Reproductive and Respiratory Syndrome Virus-Infected Swine Lung Injury.

Authors:  Meiping Yan; Make Hou; Jie Liu; Songlin Zhang; Bang Liu; Xiaoxiong Wu; Guoquan Liu
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

Review 7.  From diabetes to renal aging: the therapeutic potential of adiponectin.

Authors:  Mehdi Karamian; Maryam Moossavi; Mina Hemmati
Journal:  J Physiol Biochem       Date:  2021-02-08       Impact factor: 4.158

8.  Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop.

Authors:  Sridevi Devaraj; Natalie Torok; Mohan R Dasu; David Samols; Ishwarlal Jialal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

Review 9.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

10.  The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats.

Authors:  Asmaa I Matouk; Ashraf Taye; Mohamed A El-Moselhy; Gehan H Heeba; Abdel A Abdel-Rahman
Journal:  J Cardiovasc Pharmacol       Date:  2017-01       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.